Metabolic effects of hepatic replacement in Wilson's disease.
D000293:Adolescent; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001663:Bilirubin / Q000097:blood; D002570:Ceruloplasmin / Q000097:blood; D002648:Child; D003300:Copper / Q000097:blood / Q000378:metabolism* / Q000652:urine; D003520:Cyclophosphamide / Q000627:therapeutic use; D006527:Hepatolenticular Degeneration / Q000378:metabolism* / Q000628:therapy; D006801:Humans; D007165:Immunosuppression Therapy; D008099:Liver / Q000378:metabolism; D008103:Liver Cirrhosis / Q000209:etiology; D016031:Liver Transplantation; D008297:Male; D011241:Prednisone / Q000627:therapeutic use
D000961:Antilymphocyte Serum; D003300:Copper; D003520:Cyclophosphamide; D002570:Ceruloplasmin; D001379:Azathioprine; D001663:Bilirubin; D011241:Prednisone